Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $358.79B as of Saturday, July 25, 2026.
ENTERPRISE VALUE (EV)
$358.79B
Merck & Co., Inc.
Market Cap
$323.72B
Enterprise Value (EV)
$358.79B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Merck & Co., Inc. (MRK) | $323.72B | $358.79B |
| UnitedHealth Group Incorporated (UNH)vs › | $382.09B | $423.95B |
| AstraZeneca PLC (AZN)vs › | $262.31B | $288.67B |
| Novo Nordisk A/S (NVO)vs › | $216.72B | $236.04B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | $249.66B |
| Amgen Inc. (AMGN)vs › | $202.95B | $248.24B |
| AbbVie Inc. (ABBV)vs › | $458.11B | $521.58B |
| Abbott Laboratories (ABT)vs › | $179.58B | $206.82B |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | $175.09B |
| Pfizer Inc. (PFE)vs › | $139.86B | $202.62B |
Market Cap
$323.72B
Total Debt
$49.63B
Cash
$14.56B
Enterprise Value
$358.79B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
